Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) has a beta of 1.10, a 12-month trailing P/E ratio of 81.42, and a growth ratio of 5.82. The
Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) shares fell to a low of $90.91 before closing at $91.30. Intraday shares traded counted 0.82 million, which was
Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) previous close was $89.47 while the outstanding shares total 223.92M. The firm has a beta of 1.11, a 12-month
Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) shares traded lower over the last trading session, losing -0.46% on 05/28/21. The shares fell to a low of
Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) shares traded higher over the last trading session, gaining 0.56% on 05/25/21. The shares fell to a low of
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
